Literature DB >> 8986711

Receptor editing, immune diversification, and self-tolerance.

M Z Radic1, M Zouali.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8986711     DOI： 10.1016/s1074-7613(00)80266-6

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  34 in total

1.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival.

Authors:  D Nemazee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.

Authors:  Muriel Viau; Nancy S Longo; Peter E Lipsky; Lars Björck; Moncef Zouali
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  Editing and escape from editing in anti-DNA B cells.

Authors:  Salar N Khan; Esther J Witsch; Noah G Goodman; Anil K Panigrahi; Ching Chen; Yufei Jiang; Amy M Cline; Jan Erikson; Martin Weigert; Eline T Luning Prak; Marko Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

7.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

8.  Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes.

Authors:  U Braun; K Rajewsky; R Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus.

Authors:  T Dörner; S J Foster; N L Farner; P E Lipsky
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.

Authors:  Masashi Morita; Gordon Stamp; Peter Robins; Anna Dulic; Ian Rosewell; Geza Hrivnak; Graham Daly; Tomas Lindahl; Deborah E Barnes
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.